Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
93,766
-
Share change
-
+93,766
-
Total reported value
-
$260,330
-
Price per share
-
$2.78
-
Number of holders
-
7
-
Value change
-
+$260,330
-
Number of buys
-
7
Institutional Holders of ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) as of Q1 2023
As of 31 Mar 2023,
ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,766 shares.
The largest 7 holders included
MORGAN STANLEY, OLD MISSION CAPITAL LLC, Twin Lakes Capital Management, LLC, Providence Capital Advisors, LLC, ADVISOR GROUP HOLDINGS, INC., Sugarloaf Wealth Management, LLC, and Steward Partners Investment Advisory, LLC.
This page lists
7
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.